Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search
RimAsia Capital Partners

RimAsia Capital Partners

A Wan Chai-based venture capital firm that invests in the mid market sector within Asia

All edits

Edits on 23 Sep, 2022
Megan Gustafson
Megan Gustafson edited on 23 Sep, 2022
Edits made to:
Topic thumbnail

RimAsia Capital Partners

A Wan Chai-based venture capital firm that invests in the mid market sector within Asia

Semyon Kolychev"Edit from table cell"
Semyon Kolychev edited on 23 Sep, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 9 Aug, 2022
Golden AI"Merge infobox in utils"
Golden AI edited on 9 Aug, 2022
Edits made to:
Infobox (-1 properties)
Infobox
Invested in
Edits on 28 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 28 Jul, 2022
Edits on 5 Jul, 2022
Golden AI"remove blacklisted domain URLs"
Golden AI edited on 5 Jul, 2022
Edits on 6 Jun, 2022
Katrina-Kay Pettitt"prospector:1580:1248717"
Katrina-Kay Pettitt edited on 6 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 5 Apr, 2022
Katrina-Kay Pettitt"prospector:1398:578190"
Katrina-Kay Pettitt edited on 5 Apr, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 23 Apr, 2021
Golden AI
Golden AI edited on 23 Apr, 2021
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 Mar, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 17 Mar, 2020
Edits made to:
Article (+20/-20 characters)
Article

RimAsia Capital Partners is a venture capital firmventure capital firm in Wan Chai that prefers to invest in the mid market sector within Asia. Founded 2004 in Wan Chai, Hong Kong, the firm invests in private equity rounds. The notable investment portfolio of RimAsia Capital Partners includes Caladrius Biosciences, and Actions Semiconductor. As of February 2020, RimAsia Capital Partners has made two investments. Their most recent investment was on April 13, 2009, when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two exits, the most notable of which include Caladrius Biosciences and Actions Semiconductor.

Edits on 12 Mar, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 12 Mar, 2020
Edits made to:
Article (+21/-21 characters)
Article

RimAsia Capital Partners is a venture capital firm in Wan Chai that prefers to invest in the mid market sector within Asia. Founded 2004 in Wan Chai, Hong Kong, the firm invests in private equity rounds. The notable investment portfolio of RimAsia Capital Partners includes Caladrius Biosciences, and Actions SemiconductorActions Semiconductor. As of February 2020, RimAsia Capital Partners has made two investments. Their most recent investment was on April 13, 2009, when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two exits, the most notable of which include Caladrius Biosciences and Actions Semiconductor.

Edits on 8 Mar, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 8 Mar, 2020
Edits made to:
Article (+21/-21 characters)
Article

RimAsia Capital Partners is a venture capital firm in Wan Chai that prefers to invest in the mid market sector within Asia. Founded 2004 in Wan Chai, Hong Kong, the firm invests in private equity rounds. The notable investment portfolio of RimAsia Capital Partners includes Caladrius BiosciencesCaladrius Biosciences, and Actions Semiconductor. As of February 2020, RimAsia Capital Partners has made two investments. Their most recent investment was on April 13, 2009, when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two exits, the most notable of which include Caladrius Biosciences and Actions Semiconductor.

Edits on 3 Mar, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 3 Mar, 2020
Edits made to:
Article (+8/-8 characters)
Article

RimAsia Capital Partners is a venture capital firm in Wan ChaiWan Chai that prefers to invest in the mid market sector within Asia. Founded 2004 in Wan Chai, Hong Kong, the firm invests in private equity rounds. The notable investment portfolio of RimAsia Capital Partners includes Caladrius Biosciences, and Actions Semiconductor. As of February 2020, RimAsia Capital Partners has made two investments. Their most recent investment was on April 13, 2009, when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two exits, the most notable of which include Caladrius Biosciences and Actions Semiconductor.

Edits on 27 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 27 Feb, 2020
Edits made to:
Article (+9/-9 characters)
Article

RimAsia Capital Partners is a venture capital firm in Wan Chai that prefers to invest in the mid market sector within Asia. Founded 2004 in Wan Chai, Hong KongHong Kong, the firm invests in private equity rounds. The notable investment portfolio of RimAsia Capital Partners includes Caladrius Biosciences, and Actions Semiconductor. As of February 2020, RimAsia Capital Partners has made two investments. Their most recent investment was on April 13, 2009, when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two exits, the most notable of which include Caladrius Biosciences and Actions Semiconductor.

Edits on 12 Feb, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 12 Feb, 2020
Edits made to:
Article (+4/-4 characters)
Article

RimAsia Capital Partners is a venture capital firm in Wan Chai that prefers to invest in the mid market sector within AsiaAsia. Founded 2004 in Wan Chai, Hong Kong, the firm invests in private equity rounds. The notable investment portfolio of RimAsia Capital Partners includes Caladrius Biosciences, and Actions Semiconductor. As of February 2020, RimAsia Capital Partners has made two investments. Their most recent investment was on April 13, 2009, when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two exits, the most notable of which include Caladrius Biosciences and Actions Semiconductor.

Edits on 8 Feb, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 8 Feb, 2020
Edits made to:
Description (+87 characters)
Article (+615 characters)
Topic thumbnail

RimAsia Capital Partners

A Wan Chai-based venture capital firm that invests in the mid market sector within Asia

Article

RimAsia Capital Partners is a venture capital firm in Wan Chai that prefers to invest in the mid market sector within Asia. Founded 2004 in Wan Chai, Hong Kong, the firm invests in private equity rounds. The notable investment portfolio of RimAsia Capital Partners includes Caladrius Biosciences, and Actions Semiconductor. As of February 2020, RimAsia Capital Partners has made two investments. Their most recent investment was on April 13, 2009, when Caladrius Biosciences raised $11M. RimAsia Capital Partners has had two exits, the most notable of which include Caladrius Biosciences and Actions Semiconductor.

Edits on 4 Feb, 2020
Marie Gabrielle Laguna- Bedia
Marie Gabrielle Laguna- Bedia edited on 4 Feb, 2020
Edits made to:
Infobox (+5/--1 properties)
Timeline (+1 events) (+7 characters)
Table (+3 rows) (+6 cells) (+100 characters)
Table (+2 rows) (+2 cells) (+43 characters)
Table

Name
Role
LinkedIn

Eric Lin Ph.D

Partner

Eric Wei

Managing Partner & Co-Founder

Synthia Hillberry

Chief Financial Officer

Table

Company
CEO
Location
Products/Services

Actions Semiconductor

Caladrius Biosciences

Infobox
Location
Company status
Closed
Founded date
2004
Invested in
Timeline

2004

Founded
Edits on 11 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 11 Jul, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 9 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul, 2019
Golden AI"Initial topic creation"
Golden AI created this topic on 9 Jul, 2019
Edits made to:
Topic thumbnail

 RimAsia Capital Partners

A Wan Chai-based venture capital firm that invests in the mid market sector within Asia

Golden logo
By using this site, you agree to our Terms & Conditions.